iShares MSCI France ETF vs 22nd Century Group Inc — how do they compare? iShares MSCI France ETF trades at $41.52 (market cap $330.91M), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: iShares MSCI France ETF is far larger — about 532.3× 22nd Century Group Inc's market cap, and iShares MSCI France ETF is more actively traded (556,654 versus 45,625). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI France ETF for 55 Days and 22nd Century Group Inc for 32 Days on average.
| EWQ | XXII | |
|---|---|---|
Market Cap | $330.91M | $621.67K |
Volume | 556,654 | 45,625 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $48.35 | $483.00 |
52-Week Low | $41.32 | $0.80 |
Typical Hold Time | 55 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
EWQ is trading at $41.52 with a slight 0.44% daily gain, though technical indicators show a bearish bias with moving averages signaling strong selling pressure. The stock faces mixed sentiment with oscillators suggesting potential oversold conditions while European market uncertainties create headwinds. Recent news highlights ECB rate hikes and energy-driven inflation concerns affecting European equities.
The stock's outlook remains cautious with technical weakness offset by potential oversold bounce opportunities. Key risks include European economic sentiment deterioration and persistent inflation pressures, while the absence of fundamental data requires careful monitoring of upcoming financial disclosures for valuation clarity.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.
Read more on EWQ →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →